Mediscore
Debt Financing in 2020
Mediscore Health, founded in 2017, is based in Philadelphia, Pennsylvania with an additional location in Santa Monica, California. The company specializes in providing data-driven insights for healthcare solutions, focusing on chronic care management and risk adjustment for Medicare Advantage payers and Accountable Care Organizations (ACOs). Mediscore Health offers services such as physician-driven chart review and analytics, predictive diagnostics, and point-of-care disease management. Their technology-enabled approach is designed to help providers diagnose, document, and manage chronically ill patients effectively at the primary care level.
OsciFlex
Debt Financing in 2020
OsciFlex LLC, established in 2017 and headquartered in Philadelphia, Pennsylvania, specializes in developing a medical device aimed at preventing blood clots from forming at valves. The company's innovative product mimics nature's process to provide more effective compression therapy, reducing the risk of Venous thromboembolism (VTE) in patients and potentially decreasing reliance on costly and risky anti-coagulation pharmaceuticals.
Keriton
Seed Round in 2017
Keriton provides a digital platform for managing inpatient feeding, focusing on patient safety and improving nursing workflows. Its system tracks milk-bottle inventory, recipes, feeding orders, expiry dates, and more from mobile devices. It also offers a media-sharing platform for nurses to connect NICU babies with their mothers and delivers real-time insights into milk production patterns.
Grand Round Table
Seed Round in 2015
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.
Prescribe Well
Seed Round in 2015
PrescribeWell, Inc. is a technology company based in Hatfield, Pennsylvania, that specializes in developing a platform-as-a-service (PaaS) designed for healthcare providers and integrated healthcare systems. The platform facilitates the tracking and analysis of behavioral modifications related to health issues such as obesity, smoking cessation, and stress management. By integrating seamlessly with existing electronic medical records (EMR) systems, PrescribeWell provides a physician-centric hub that enhances patient engagement and facilitates wellness regimens. The solution not only supports healthcare providers in managing ongoing patient communications but also optimizes billing processes, thereby improving overall healthcare delivery. Incorporated in 2012, PrescribeWell aims to support healthcare professionals in achieving better patient health outcomes through effective lifestyle modifications and disease prevention strategies.
Stabiliz Orthopaedics
Seed Round in 2014
Stabiliz Orthopaedics, LLC is a company based in Exton, Pennsylvania, that specializes in the development and distribution of orthopedic devices. Founded in 2009, the company focuses on creating innovative enhancements to orthopedic medical technologies that are FDA approved. Stabiliz Orthopaedics aims to improve clinical outcomes and reduce healthcare costs, addressing the challenges faced by healthcare systems. Through its commitment to advancing orthopedic care, the company seeks to provide effective solutions that enhance patient treatment and recovery.
Infarct Reduction Technologies
Seed Round in 2014
Infarct Reduction Technologies develops a therapeutic device for ischemic pre-conditioning protocol. The company offers LifeCuff, a non-invasive manually-inflated blood pressure cuff for remote ischemic conditioning in heart attack, stroke, sepsis, liver surgery, traumatic brain injury, and other critical condition patients.
The company is headquartered in Waldwick, New Jersey.
Grand Round Table
Seed Round in 2014
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.
NetMinder
Seed Round in 2014
NetMinder specializes in providing a network comparison tool designed for medical, dental, vision, and behavioral health plan provider networks. The company's platform features an intuitive interface that allows users to generate detailed reports and analyses swiftly, facilitating improved decision-making for payers, brokers, and consultants. By offering easily shareable reports and the capability to quickly incorporate new competitors, NetMinder enhances the efficiency of sales teams and recruiters. This objective and validated source of provider network data enables clients to make informed employee benefit decisions, ultimately leading to increased recruitment of providers, more closed deals, and improved client retention.
Stabiliz Orthopaedics
Seed Round in 2012
Stabiliz Orthopaedics, LLC is a company based in Exton, Pennsylvania, that specializes in the development and distribution of orthopedic devices. Founded in 2009, the company focuses on creating innovative enhancements to orthopedic medical technologies that are FDA approved. Stabiliz Orthopaedics aims to improve clinical outcomes and reduce healthcare costs, addressing the challenges faced by healthcare systems. Through its commitment to advancing orthopedic care, the company seeks to provide effective solutions that enhance patient treatment and recovery.
Ceptaris Therapeutics
Series B in 2006
Ceptaris Therapeutics, Inc. is a privately held specialty pharmaceutical company focused on developing innovative treatments for rare cancers. The company is working on a proprietary gel formulation of mechlorethamine hydrochloride aimed at treating early-stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If successful, this investigational drug would be the first topical mechlorethamine product available to alleviate the signs and symptoms associated with this condition. In addition to its primary focus on CTCL, Ceptaris is also advancing YT-1006, an NMDA antagonist designed for treating neuropathic pain while mitigating side effects through a unique stereochemistry approach.
Acuity Pharmaceuticals
Series B in 2004
Acuity Pharmaceuticals is a pharmaceutical company based in Philadelphia, Pennsylvania, that specializes in developing treatments for ophthalmic diseases, particularly age-related macular degeneration and diabetic retinopathy. Founded in 2007, the company focuses on innovative therapies, including its clinical compound Cand5, a small interfering RNA therapeutic designed to treat vision loss by targeting vascular endothelial growth factor. In June 2011, Acuity Pharmaceuticals was acquired by OPKO Health, further enhancing its capabilities in the field of eye care.